Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harmonium International is a Canadian biotechnology company specializing in the development and commercialization of probiotic-based natural health products. Founded in Montreal, the company became a leader in the probiotic industry by focusing on high-quality, clinically documented strains designed to improve digestive and immune health. Their expertise encompasses the entire value chain, from strain selection and formulation to manufacturing and distribution. In January 2010, Harmonium International was acquired by Atrium Innovations for approximately $21.5 million to bolster Atrium's presence in the rapidly growing probiotic sector. Today, its legacy continues through the various probiotic brands managed under the Nestlé Health Science umbrella.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harmonium International.